Biden Administration’s Fentanyl Proposal Would Create Severe Criminal Penalties for People Struggling with Addiction and Restrict Research

Statement Maritza Perez Medina August 1, 2024
Media Contact

Maggie Hart, [email protected]

Washington, D.C. Yesterday, the Biden-Harris Administration announced a proposal to counter fentanyl and synthetic drugs. In addition to providing support for tools to detect illicit drugs, the proposal would permanently designate fentanyl-related substances (FRS) as Schedule I drugs and xylazine as a Schedule III drug on the Controlled Substances Act (CSA), both of which would impose severe criminal penalties on people who use drugs and block research that could lead to lifesaving overdose interventions.

In response to today’s proposal, Maritza Perez Medina, Director, Federal Affairs at the Drug Policy Alliance (DPA), released the following statement:

“With this proposal, unfortunately, the Administration is doubling down on the same failed drug war tactics of the past, rather than prioritizing the public health strategies that will actually save lives. We know that supply-side strategies and criminalization only exacerbate negative health outcomes and create further barriers to treatment, housing, and stability. After more than 50 years of a failed drug war, illicit drugs are still widely available, and the illicit drug supply is deadlier than ever. A focus on enforcement has led to the development of more potent drugs that are harder for law enforcement to detect. Since fentanyl-related substances were criminalized at the federal level in 2018, overdose rates have only increased, from 67,367 overdose deaths in 2018 to 107,941 in 2022.

“This ineffective proposal would also hinder efforts to deliver evidence-based health services to people in need. Permanently scheduling xylazine and fentanyl-related substances restricts research, which would make it more difficult to better understand how to treat people with substance use disorder and prevent overdose deaths involving these drugs. With thousands of lives at stake, it is imperative for the Administration and Congress to focus on evidence-based solutions that save lives, rather than disproven tactics as a false promise of change. We urge the Administration to support–and Congress to pass–legislation that utilizes evidence-based health approaches to the overdose crisis that are proven to work, such as the TEST Act, the Stop Fentanyl Overdoses Act, The Reentry Act, the Modernizing Opioid Treatment Access Act, and the CARE Act.”

Background:

Learn more about why we need a health approach to fentanyl. 

### 

 

About the Drug Policy Alliance 

The Drug Policy Alliance is the leading organization in the U.S. working to end the drug war, repair its harms, and build a non-punitive, equitable, and regulated drug market. We envision a world that embraces the full humanity of people, regardless of their relationship to drugs. We advocate that the regulation of drugs be grounded in evidence, health, equity, and human rights. In collaboration with other movements and at every policy level, we change laws, advance justice, and save lives. Learn more at drugpolicy.org.

A young woman holds a sign that says "End the Drug War."

Sign up for updates from DPA.

2024 Election Update

TRUMP WANTS MORE DRUG WAR

Not on our watch! Help us prepare for the fight ahead.
en_USEnglish